TechLife Capital Overview

TechLife Capital is a Paris-based growth equity fund dedicated to the Healthcare and Technology sectors. Managed by an independent firm approved by the French AMF and recognized with the Innovation Financing label from the French Ministry of Economy and Finance, the fund focuses on nine targeted sectors: pharmaceutical industry, medical services, medical devices, software, services, solutions, health software, medtech, and health data. TechLife Capital employs a proactive investment strategy, identifying promising market verticals characterized by accelerating demand and fragmented offerings. The fund aims to more than double the size of its portfolio companies, assisting them in becoming French leaders with European or global reach. Equity commitments range from €5 million to €50 million, with flexibility in structuring investments, including capital increases or acquisitions of existing equity, and taking majority or minority positions. Targeted companies typically have a French initial dimension, proven business models, profitability, and clear ambitions for significant international expansion.

Is TechLife Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with TechLife Capital, along with a list of other relevant VCs, is available on Hopohopo.io.